News
Announcements and coverage.
Company news, programme milestones and selected press. For media enquiries, use the contact page.
Sep 2026
1859 appoints Dr. Helena Marsh as Chief Scientific Officer
Company announcement
Jun 2026
Second programme reaches lead optimisation
Company announcement
Feb 2026
Pico-scale screening method published in Nature Chemical Biology
Publication
Oct 2025
1859 expands La Jolla facility to add cell-based screening capacity
Company announcement
May 2025
Research partnership to apply the platform to an undisclosed inflammation target
Partnering
Jun 2023
Sanket Agrawal appointed Chief Executive Officer
Company announcement
Feb 2022
1859 launches with $40 million Series A to industrialise new medicine discovery
Press release